ArticleInvestigational new drugs2024

Predictive value of ZFHX4 mutation for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer and melanoma.

Cong Fu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.